Methylprednisolone Versus Dexamethasone in COVID-19: A Meta-Analysis of Nonrandomized Studies.

导出 LinkOut

翻译打印收藏纠错

作者： Azizullah,Beran ^[1] ; Hazem,Ayesh ^[1] ; Mohammed,Mhanna ^[1] ; Omar,Srour ^[1] ; Rami,Musallam ^[2] ; Wasef,Sayeh ^[1] ; Waleed,Khokher ^[1] ; Nehaya,Altorok ^[1] ; Zaid,Noori ^[3] ; Ragheb,Assaly ^[1] ; Nezam,Altorok ^[3]

作者单位： Department of Internal Medicine, University of Toledo, Toledo, OH. ^[1] Department of Internal Medicine, St. Vincent Charity Medical Center, Cleveland, OH. ^[2] Division of Pulmonary and Critical Care Medicine, University of Toledo, Toledo, OH. ^[3] Division of Rheumatology, University of Toledo, Toledo, OH. ^[4]

主题词地塞米松(Dexamethasone);糖皮质激素类(Glucocorticoids);人类(Humans);甲泼尼龙(Methylprednisolone)

DOI 10.1097/MJT.0000000000001506

PMID 35533326

发布时间 2022-12-07

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

American journal of therapeutics

e354-e357页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Methylprednisolone Versus Dexamethasone in COVID-19: A Meta-Analysis of Nonrandomized Studies.

American journal of therapeutics

相似文献

American journal of therapeutics

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Methylprednisolone Versus Dexamethasone in COVID-19: A Meta-Analysis of Nonrandomized Studies.

American journal of therapeutics

相似文献

American journal of therapeutics

相关期刊

检索历史清除